Your browser doesn't support javascript.
loading
Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
D'Aguanno, Simona; Valentini, Elisabetta; Tupone, Maria Grazia; Desideri, Marianna; Di Martile, Marta; Spagnuolo, Manuela; Buglioni, Simonetta; Ercolani, Cristiana; Falcone, Italia; De Dominici, Marco; Milella, Michele; Rizzo, Maria Giulia; Calabretta, Bruno; Cota, Carlo; Anichini, Andrea; Trisciuoglio, Daniela; Del Bufalo, Donatella.
Afiliação
  • D'Aguanno S; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. simona.daguanno@ifo.gov.it.
  • Valentini E; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Tupone MG; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Desideri M; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Di Martile M; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Spagnuolo M; Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Buglioni S; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ercolani C; Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Falcone I; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • De Dominici M; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Milella M; Medical Oncology 1, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Rizzo MG; Oncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Calabretta B; Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Cota C; Dermatopathology Unit, IRCCS San Gallicano Dermatological Institute, Rome, Italy.
  • Anichini A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Trisciuoglio D; Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Del Bufalo D; Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
J Exp Clin Cancer Res ; 37(1): 278, 2018 Nov 19.
Article em En | MEDLINE | ID: mdl-30454024
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas c-bcl-2 / Proteínas Proto-Oncogênicas c-myb / MicroRNAs / Melanoma / Proteínas de Membrana / Proteínas do Tecido Nervoso Limite: Animals / Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Proteínas Proto-Oncogênicas c-bcl-2 / Proteínas Proto-Oncogênicas c-myb / MicroRNAs / Melanoma / Proteínas de Membrana / Proteínas do Tecido Nervoso Limite: Animals / Female / Humans Idioma: En Revista: J Exp Clin Cancer Res Ano de publicação: 2018 Tipo de documento: Article